Quoin Pharmaceuticals QNRX
NASDAQ QNRX
$6.97 -0.18 (-2.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020)

Quoin Pharmaceuticals' (QNRX) quarterly Operating Leases came in at $122000.0 in Q4 2020, down 21.29% quarter-over-quarter from $155000.0 in Q2 2020.

Analysis

Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020) Analysis & Trends

Quoin Pharmaceuticals has disclosed Operating Leases across 2 years of filings, most recently posting $122000.0 for Q4 2020.

  • In Q4 2020, Operating Leases changed N/A year-over-year to $122000.0; the TTM figure through Dec 2020 stood at $122000.0 (changed N/A YoY), while the FY2020 annual figure was $122000.0, changed N/A from the prior year.
  • Operating Leases came in at $122000.0 for Q4 2020 at Quoin Pharmaceuticals, down from $155000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $243000.0 in Q2 2019 to a low of $122000.0 in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 Quoin Pharmaceuticals 685,561.82 685,561.82 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 122,000.00
Jun 30, 2020 155,000.00
Jun 30, 2019 243,000.00